ClinVar Miner

Submissions for variant NM_001127222.2(CACNA1A):c.7266_7271del (p.Ser2423_Gly2424del)

dbSNP: rs775428832
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Center for Personalized Medicine, Children's Hospital Los Angeles RCV000735366 SCV000854520 uncertain significance Autistic behavior; Specific learning disability; Abnormal basal ganglia morphology; Abnormal globus pallidus morphology; Bilateral basal ganglia lesions; Abnormal substantia nigra morphology; Attention deficit hyperactivity disorder criteria provided, single submitter clinical testing
Mendelics RCV000990163 SCV001141006 likely benign Episodic ataxia type 2 2019-05-28 criteria provided, single submitter clinical testing
Ambry Genetics RCV002536537 SCV003690400 likely benign Inborn genetic diseases 2021-12-28 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago RCV003227847 SCV003924185 uncertain significance Episodic ataxia type 2; Spinocerebellar ataxia type 6; Migraine, familial hemiplegic, 1; Developmental and epileptic encephalopathy, 42 2021-03-30 criteria provided, single submitter clinical testing CACNA1A NM_001127222.1 exon 47 p.Ser2423_Gly2424del (c.7266_7271del): This variant has not been reported in the literature but is present in 0.2% (45/17222) of Latino alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs775428832). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant represents an in-frame deletion of 2 amino acids at position 2423/2424 and is not predicted to alter the reading frame. However, the effect of this variant on the protein is unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain.
CeGaT Center for Human Genetics Tuebingen RCV003424326 SCV004137964 likely benign not provided 2024-07-01 criteria provided, single submitter clinical testing CACNA1A: PM4, BS1
PreventionGenetics, part of Exact Sciences RCV003985425 SCV004755895 likely benign CACNA1A-related disorder 2019-07-12 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
GenomeConnect - Brain Gene Registry RCV003227847 SCV004804630 not provided Episodic ataxia type 2; Spinocerebellar ataxia type 6; Migraine, familial hemiplegic, 1; Developmental and epileptic encephalopathy, 42 no assertion provided phenotyping only Variant classified as Uncertain significance and reported on 05-13-2021 by Vanderbilt University Medical Center. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.